Author

Brendan Flannery

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Comparative immunogenicity and relative vaccine efficacy of recombinant and cell culture-based influenza vaccines: Results from a randomized trial of adults in the United States, 2024-2025

Background: Recombinant (RIV) and cell culture-based inactivated (ccIIV) influenza vaccines could improve seasonal influenza prevention; however, evidence is limited in how protection may differ among non-egg-based vaccines. Methods: We conducted a randomized trial of RIV versus ccIIV to compare vaccine immunogenicity...

K. Sumner, E. K. Noble, L. B. Grant et al. · medRxiv · 0 citations

Review Open access Jul 2026

Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016-2025.

Influenza vaccination reduced risk of fatal influenza among children with or without known underlying medical conditions, and influenza vaccine effectiveness against pediatric death from 2016 to 2017 through 2024 to 2025.

Jerome S. Leonard, Katie Reinhart, Peng-Jun Lu et al. · Pediatrics · 3 citations